Blocking Ceramide Production Might Prevent Type 2 Diabetes

Share this content:
Blocking Ceramide Production Might Prevent Type 2 Diabetes
Blocking Ceramide Production Might Prevent Type 2 Diabetes

FRIDAY, Nov. 4, 2016 (HealthDay News) -- High ceramide levels may increase diabetes risk, while low levels could protect against the disease, according to findings from an experimental study published online Nov. 3 in Cell Metabolism.

Noting that overnutrition, inflammatory cytokines, glucocorticoids, and other stress stimuli enhance the rate of sphingolipid synthesis, Bhagirath Chaurasia, Ph.D., from the Laboratory of Translational Metabolic Health in Melbourne, Australia, and colleagues examined the role of this spillover sphingolipid synthesis pathway in adipose function.

The researchers found that, compared to body mass index-matched individuals without diabetes, subcutaneous adipose tissue of patients with type 2 diabetes had considerably more sphingolipids. In mice, whole-body and adipose tissue-specific inhibition or deletion of the first enzyme in the sphingolipid biosynthesis cascade -- serine palmitoyltransferase -- markedly altered adipose morphology and metabolism, especially in subcutaneous adipose tissue. The decline in adipose sphingolipids correlated with increases in brown and beige/brite adipocyte numbers, mitochondrial activity, and insulin sensitivity. In addition, there were increases in the numbers of anti-inflammatory M2 macrophages in the adipose bed and induction of insulin-sensitizing adipokine secretion.

"By blocking ceramide production, we might be able to prevent the development of type 2 diabetes or other metabolic conditions, at least in some people," Chaurasia said in a statement.

One author disclosed financial ties to Centaurus Therapeutics.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »